Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2026 09:15 ET | Source: Longeveron

Longeveron to Present at BIO International Convention 2026

Longeveron will present at BIO 2026. CEO, CFO & BD will host meetings to explore partnership opportunities for its 4 stem cell therapy developmet programs.
May 20, 2026 16:05 ET | Source: Longeveron

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

Longeveron CEO issues 2026 Letter to Stockholders.
May 13, 2026 16:05 ET | Source: Longeveron

Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update

Longeveron (LGVN), developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, reported 1Q26 financial results.